The maternal immune system protects developing offspring against pathogens before birth
via transplacental transfer and after birth through secreted milk. This transferred maternal …

Immunization has the potential to become a viable weapon for the upcoming pandemic and
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …

Elucidating optimal vaccine adjuvants for harnessing age-specific immune pathways to
enhance magnitude, breadth, and durability of immunogenicity remains a key gap area in …

Given the efficacy and safety issues of the WHO for approved/prequalified live attenuated
rotavirus (RV) vaccines, studies on alternative non-replicating modals and proper RV …

Background Afghanistan introduced monovalent rotavirus vaccine (Rotarix) into its national
immunisation schedule in January, 2018. While post-licensure studies have shown …

Overcoming interfering impacts of pre-existing immunity to generate universally protective
influenza A virus (IAV)-specific T cell immunity through vaccination is a high priority. In this …

Rotavirus diarrhea-associated illness remains a major cause of global death in children
under five, attributable in part to discrepancies in vaccine performance between high-and …

High titres of rotavirus-specific maternal antibodies may contribute to lower rotavirus vaccine
efficacy in low-and middle-income countries (LMICs). RV3-BB vaccine (G3P [6]) is based on …

Inconveniences associated with the efficacy and safety of the World Health Organization
(WHO) approved/prequalified live attenuated rotavirus (RV) vaccines, sounded for finding …

Mozambique introduced the monovalent rotavirus vaccine (Rotarix®, GSK Biologicals,
Rixensart, Belgium) in September 2015. Previous analysis, showed that Nampula province …